Status:
RECRUITING
Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer
Head &Amp;Amp; Neck Squamous Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Delays between surgery and the initiation of post-operative radiotherapy (S-PORT) in head and neck cancer (HNC) patients are prevalent and associated with worse oncologic outcomes. This pilot study ev...
Eligibility Criteria
Inclusion
- All adult patients (age 18 or older).
- Pathologically confirmed oral cavity or laryngeal squamous cell carcinoma.
- Diagnosed from July 2024 to September 2026.
- With planned primary intention surgical resection.
- With or without adjuvant therapy.
- Treated at the Centre Hospitalier de l'Université de Montréal.
Exclusion
- Patients who do not end up receiving surgery.
- S-PORT \> 180 days
Key Trial Info
Start Date :
August 21 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 21 2029
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT07180901
Start Date
August 21 2025
End Date
October 21 2029
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada, H2X 0C1